Advisory Research Inc Horizon Therapeutics Public LTD CO Transaction History

Advisory Research Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $244,482 - $310,652	-2,829 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$98.56 - $119.91 $201,062 - $244,616	-2,040 Reduced 41.9%	2,829 $305,000
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $25,785 - $28,680	299 Added 6.54%	4,869 $456,000
Q1 2021 May 12, 2021	BUY	$71.83 - $95.48 $48,700 - $64,735	678 Added 17.42%	4,570 $421,000
Q4 2020 Feb 12, 2021	SELL	$67.0 - $84.39 $13,199 - $16,624	-197 Reduced 4.82%	3,892 $285,000
Q3 2020 Nov 12, 2020	SELL	$55.23 - $79.93 $67,380 - $97,514	-1,220 Reduced 22.98%	4,089 $318,000
Q2 2020 Aug 13, 2020	SELL	$30.2 - $56.98 $493,739 - $931,566	-16,349 Reduced 75.49%	5,309 $295,000
Q1 2020 May 12, 2020	SELL	$24.87 - $38.56 $574,621 - $890,928	-23,105 Reduced 51.62%	21,658 $642,000
Q4 2019 Feb 11, 2020	BUY	$25.43 - $36.67 $207,763 - $299,593	8,170 Added 22.33%	44,763 $1.62 Million
Q3 2019 Nov 12, 2019	SELL	$23.0 - $27.97 $185,610 - $225,717	-8,070 Reduced 18.07%	36,593 $996,000
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $1.02 Million - $1.27 Million	44,663 New	44,663 $1.08 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.